Structured evidence table for Rosehip Osteoarthritis Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Rosehip Osteoarthritis Meta-Analysis | It causes chronic pain, reduced mobility, and disability, affecting 607 million individuals worldwide, with nearly 46.6 million new cases annually []. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Rosehip Osteoarthritis Meta-Analysis | 11 12 13 14 15 11 15 HLA-DRB1 HLA-DQB1 Genetic polymorphisms in sterol regulatory element-binding protein 2 (rs2228314) [], interleukin-6 (rs1800795) [], and resistin (RETN) [] in Indian and Pakistani cohorts and growth differentiation factor 5 (rs143383) [],, andin Thai populations [] are linked to OA risk. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Rosehip Osteoarthritis Meta-Analysis | Need for expert opinion Despite growing clinical and mechanistic evidence for collagen supplementation in OA, several gaps and challenges remain in translating this knowledge into clinical practice, especially in the Indian subcontinent and Southeast Asia. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Rosehip Osteoarthritis Meta-Analysis | 1 2 3 4 6 7 8 9 10 1 Osteoarthritis (OA) is the most prevalent degenerative joint disease globally and the second most common rheumatologic condition []. | 4 | Muacevic Alexander (2026) | Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion |
| Rosehip Osteoarthritis Meta-Analysis | 1 2 [3] [4] [5] Physical activity and pharmacological treatment are both well-established, evidence-based interventions for managing osteoarthritis (OA)-related symptoms. | 4 | Dahlberg Leif E. (2026) | Baseline pain medication is associated with longer duration of high adherence in a three-month digital treatment program for hip and knee osteoarthritis |
| Rosehip Osteoarthritis Meta-Analysis | International guidelines consistently recommend exercise and education as first-line OA management with the addition of pharmacological support as needed [,]. | 4 | Dahlberg Leif E. (2026) | Baseline pain medication is associated with longer duration of high adherence in a three-month digital treatment program for hip and knee osteoarthritis |
| Rosehip Osteoarthritis Meta-Analysis | Clinical studies have shown that digital therapy providing evidence-based OA treatment via an app are associated with clinically meaningful reductions in pain, improved physical function, improved symptom state, and in some cases a reduced need for joint replacement surgery [,,]. | 4 | Dahlberg Leif E. (2026) | Baseline pain medication is associated with longer duration of high adherence in a three-month digital treatment program for hip and knee osteoarthritis |
Source documents